TMC Life Sciences Berhad (KLSE:TMCLIFE)
0.4450
+0.0050 (1.14%)
At close: Aug 28, 2026
TMC Life Sciences Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 775 | 784 | 749 | 1,150 | 1,045 | 888 | |
Market Cap Growth | 1.14% | 4.65% | -34.85% | 10.00% | 17.65% | -18.40% |
Enterprise Value | 805 | 822 | 822 | 1,167 | 1,116 | 960 |
Last Close Price | 0.45 | 0.45 | 0.43 | 0.63 | 0.56 | 0.48 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 44.60 | 45.10 | 207.71 | 28.28 | 26.62 | 21.46 |
Forward PE | - | 70.00 | 70.00 | 70.00 | 70.00 | 70.00 |
PS Ratio | 1.97 | 1.99 | 2.17 | 3.32 | 3.36 | 3.64 |
PB Ratio | 0.89 | 0.90 | 0.88 | 1.30 | 1.21 | 1.07 |
P/TBV Ratio | 1.15 | 1.17 | 1.15 | 1.69 | 1.59 | 1.40 |
P/FCF Ratio | 17.63 | 17.83 | - | 23.27 | 46.23 | - |
P/OCF Ratio | 13.44 | 13.59 | 33.28 | 15.38 | 19.15 | 24.92 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.05 | 2.09 | 2.38 | 3.37 | 3.58 | 3.94 |
EV/EBITDA Ratio | 13.16 | 14.06 | 21.73 | 14.54 | 16.31 | 21.52 |
EV/EBIT Ratio | 26.53 | 27.08 | 67.27 | 20.35 | 23.72 | 29.92 |
EV/FCF Ratio | 18.32 | 18.70 | - | 23.62 | 49.36 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.21 | 0.23 | 0.25 | 0.25 |
Debt / EBITDA Ratio | 2.37 | 2.37 | 4.52 | 2.49 | 3.10 | 4.50 |
Debt / FCF Ratio | 3.30 | 3.30 | - | 4.15 | 9.69 | - |
Net Debt / Equity Ratio | 0.04 | 0.04 | 0.08 | 0.02 | 0.06 | 0.08 |
Net Debt / EBITDA Ratio | 0.52 | 0.52 | 1.89 | 0.18 | 0.74 | 1.51 |
Net Debt / FCF Ratio | 0.69 | 0.69 | -3.92 | 0.28 | 2.23 | -2.10 |
Asset Turnover | 0.35 | 0.35 | 0.30 | 0.29 | 0.27 | 0.22 |
Inventory Turnover | 14.13 | 14.13 | 17.14 | 16.68 | 15.30 | 14.73 |
Quick Ratio | 1.49 | 1.49 | 1.66 | 2.51 | 2.40 | 2.12 |
Current Ratio | 1.69 | 1.69 | 1.84 | 2.66 | 2.56 | 2.27 |
Return on Equity (ROE) | 2.02% | 2.02% | 0.41% | 4.65% | 4.65% | 5.12% |
Return on Assets (ROA) | 1.69% | 1.69% | 0.66% | 3.03% | 2.55% | 1.83% |
Return on Invested Capital (ROIC) | 2.28% | 2.25% | 0.68% | 4.88% | 5.00% | 3.74% |
Return on Capital Employed (ROCE) | 3.00% | 3.00% | 1.20% | 5.30% | 4.40% | 3.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.24% | 2.22% | 0.48% | 3.54% | 3.76% | 4.66% |
FCF Yield | 5.67% | 5.61% | -2.43% | 4.30% | 2.16% | -3.61% |
Dividend Yield | 1.25% | 1.28% | 0.43% | 0.78% | 0.74% | 0.58% |
Payout Ratio | 18.67% | 18.67% | 1070.88% | 35.99% | 12.26% | 9.32% |
Total Shareholder Return | 1.25% | 1.28% | 0.43% | 0.78% | 0.74% | 0.58% |